PORTENT 3.0 Technical Core for global health point-of-care tools
Official title: Technology Core
Funded at Cornell University · NIH-11638358 · Data updated 2026-11-12
A NIH U54 grant supports Cornell and partners in advancing point-of-care technologies for nutrition, infection, and cancer to real-world use, especially in global health settings.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cornell University NIH-funded |
| Lab location | 1 site (Ithaca, United States) |
| Project start | September 23, 2026 |
| Project end | July 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $96,102 |
| NIH project number | 3U54EB034654-04S1 |
| Project ID | NIH-11638358 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates include individuals in diverse global settings where point-of-care solutions could improve detection, screening, or management of nutrition-related deficiencies, infections, or cancer.
✕Less likely to help
Some communities may not directly benefit if tools are not yet deployed locally or if infrastructure remains insufficient.
What this research studies
This grant funds a technical core that guides how promising health technologies move from idea to clinical viability. It focuses on soliciting projects from the US and international partners, building teams, validating technologies in clinical contexts, and disseminating results. The effort looks to scale up to 6-7 parallel projects to advance solutions beyond proof-of-concept and expand into international settings. The core also emphasizes training, partnership networks, and a pathway to market through a global health accelerator.
Why it matters
Potential benefit: If successful, patients worldwide could gain access to validated, affordable point-of-care tools for nutrition, infection, and cancer care.
How similar studies have gone: Past PORTENT efforts have progressed from PoC to clinical validation and deployment in various settings, showing promise for real-world impact.
Where this research is happening
-
Cornell University
Ithaca, United States Active
Researchers
- Principal investigator: Erickson, David Carl — Cornell University
- Study coordinator: Erickson, David Carl
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.